Staging chronic pancreatitis with exocrine function tests: Are we better?

Area of Science:

• Gastroenterology and Hepatology
• Pancreatic Diseases
• Diagnostic Accuracy

Background:

• Chronic pancreatitis (CP) involves progressive pancreatic fibrosis and insufficiency.
• Current imaging lacks clear correlation with exocrine function, especially early.
• M-ANNHEIM classification aids CP staging but requires precise exocrine function assessment.

Discussion:

• Fecal elastase-1 (EF-1) offers improved detection of exocrine pancreatic insufficiency compared to acid steatocrit.
• EF-1 testing can reclassify patients to higher stages within the M-ANNHEIM system.
• Early-stage CP detection remains a challenge for EF-1 due to lower sensitivity.

Key Insights:

• EF-1 is a more accurate marker for staging CP severity using the M-ANNHEIM classification.
• Acid steatocrit and EF-1 are useful for evaluating exocrine pancreatic function.
• Accurate exocrine function tests are crucial for determining CP clinical severity.

Outlook:

• Further research may refine EF-1's role in early CP detection.
• Integration of EF-1 into clinical practice can enhance CP management and staging.
• Developing more sensitive markers for early exocrine insufficiency is warranted.